Mira Pharmaceuticals Inc (MIRA)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

Mira Pharmaceuticals Inc

Healthcare (1169)

813-369-5150

1200 BRICKELL AVENUE, MIAMI

최신 SEC 제출 서류

MIRA's Discussions on Twitter

MIRA을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
MIRA Mira Pharmaceuticals Inc	1.10	18.22M	0	-11.24M	-4.79M	-0.7615
LLY Lilly Eli Co	873.68	830.35B	45.04B	10.59B	414.30M	11.71
NVO Novo Nordisk Adr	88.08	390.99B	42.09B	14.65B	10.11B	3.2833
ABBV Abbvie Inc	202.08	356.74B	56.33B	4.28B	17.83B	2.40
JNJ Johnson Johnson	162.30	344.63B	88.82B	14.07B	18.06B	5.79
MRK Merck Co Inc	89.50	251.88B	64.17B	17.12B	14.84B	6.7297

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

Mira Pharmaceuticals Inc (MIRA) 재무 분석

Mira Pharmaceuticals Inc 주식 (MIRA) 내부자 거래

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Aminov Erez	Chief Executive Officer	Nov 20 '24	Sale	1.27	44,590	56,629	1,061,200

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc Stock (MIRA) Company Profile

MIRA을(를) 다른 주식과 비교

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

Microstrategy Inc. – 8% PRF PERPETUAL USD 100 – Ser A’s (STRK) Stock: A Week-by-Week Analysis - The News Heater

Monday.Com Ltd (MNDY) Shares Down Despite Recent Market Volatility - The News Heater

Mira Pharmaceuticals Inc (MIRA) Stock: Evaluating the Market Performance - The News Heater

Vanda Pharmaceuticals Inc (VNDA) Shares Rise Despite Market Challenges - The News Heater

Air Transport Services Group Inc (ATSG) Stock: Evaluating the Market Performance - The News Heater

Report: OpenAI's ex-CTO, Mira Murati, has recruited OpenAI co-founder John Schulman - Yahoo Finance

OpenAI cofounder John Schulman is joining Mira Murati’s startup after brief stint at Anthropic - Yahoo Finance

Kernel and Mira Launch Industry’s First $300M Secured AI API - GlobeNewswire Inc.

Mira Network Launches $10M Grant Program for AI Builders - EIN News

UCalgary researchers to validate Mira Hormone Monitor - Yahoo Finance

TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com

MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End - ACCESS Newswire

MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA - ACCESS Newswire

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study - ACCESS Newswire

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance - ACCESS Newswire

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 - ACCESS Newswire

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - ACCESS Newswire

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - ACCESS Newswire

Wealth Enhancement Advisory Services LLC Acquires 6,454 Shares of PPL Co. (NYSE:PPL) - Defense World

International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World

MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World

AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com

Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance

Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha

Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha

Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World

Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa

Mira Pharmaceuticals appoints new accounting firm - Investing.com

Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart

StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart

Should You Buy Joby Aviation Stock While It's Below $10? - Barchart

C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart

Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart

2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart

Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart

MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart

MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World

Stocks In Play: Canacol Energy Ltd. - Barchart

Grain Spreads: Profit Taking Theme - Barchart

Stocks Rally On Dovish PCE Inflation Report - Barchart

The Current State Of HR Is Unacceptable - Barchart

Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart

Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart

Is W.R. Berkley Stock Outperforming The Dow? - Barchart

PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart

US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart

Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart

Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart

Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart

Is PPG Industries Stock Underperforming The S&P 500? - Barchart

Mira Pharmaceuticals Inc (MIRA) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Mira Pharmaceuticals Inc 주식 (MIRA) 내부자 거래

MIRA과 유사한 종목